𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identifying target groups for the prevention of anxiety disorders in the general population

✍ Scribed by N. M. Batelaan; F. Smit; R. De Graaf; A. J. L. M. Van Balkom; W. A. M. Vollebergh; A. T. F. Beekman

Book ID
109342755
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
176 KB
Volume
122
Category
Article
ISSN
0001-690X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sudden gains in the treatment of general
Sudden gains in the treatment of generalized anxiety disorder
✍ Julie Present; Paul Crits-Christoph; Mary Beth Connolly Gibbons; Bridget Hearon; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 2 views

## Abstract The objective of this study was to investigate the prevalence and timing of sudden gains over the course of brief, psychodynamically oriented treatment for generalized anxiety disorder (GAD). Data were used from two studies of brief (i.e., 16‐session) supportive‐expressive psychotherapy

Efficacy of ondansetron in the treatment
Efficacy of ondansetron in the treatment of generalized anxiety disorder
✍ A. M. Freeman III; J. R. Westphal; G. T. Norris; B. A. Roggero; P. B. Webb; K. L πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 42 KB πŸ‘ 2 views

Ondansetron is a highly selective antagonist at the 5-HT 3 subtype of serotonin (5-HT) receptors . The 5-HT 3 receptors are the only receptors whose effects are mediated through the ion channels rather than the G-protein series . Ondansetron has no appreciable affinity for other 5-HT receptor subtyp